[1]许长德.探测心肌活力的技术进展[J].国际放射医学核医学杂志,2002,26(6):263-267.
　XU Chang-de.The development of imaging methods detecting the myocardial viability[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):263-267.
点击复制

探测心肌活力的技术进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
26
期数:
2002年第6期
页码:
263-267
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The development of imaging methods detecting the myocardial viability
作者:
许长德
200032 上海, 复旦大学中山医院核医学科
Author(s):
XU Chang-de
Department of Nuclear Medicine, Zhongshan Hospital Medical Center of Fudan University, Shanghai 200032, China
关键词:
心肌活力; 正电子发射体层显像; 单光子发射计算机体层显像; 核磁共振显像
Keywords:
myocardial viability; positron emission tomography; single photon emission computed tomography; magnetic resonance imaging
分类号:
R542.2;R817.4
摘要:
心肌活力的评估十分重要,它有助于了解心肌病变患者的预后和选择治疗方式。评估心肌活力的方法包括核医学和其他临床上常见的方法,其中核医学上的方法有18F-FDG PET、18F-FDG SPECT、201Tl SPECT、99Tcm-MIBI SPECT和脂肪酸显像,其他显像技术包括多巴酚丁胺负荷超声,MRI(核磁共振显像)等。
Abstract:
The measurement of the myocardial viability is important to evaluate the prognosis and select the operation pattern of the patients undergoing the coronary bypass surgery.Various techniques have been developed to identify viable myocardium including 18F-FDG PET,18F-FDG SPECT,201Tl SPECT,99Tcm-sestamibi SPECT and fatty acid imaging in the nuclear medicine.The other clinical techniques including the dobutamine stress echocardiography and magnetic resonance imaging (MRI)methods can also assess myocardial viability.

参考文献/References:

[1] Hass F, Haehnl CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative risk in patients with advanced ischemic heart disease[J]. J Am Coll Cardiol, 1997, 30(7):1693-1700.
[2] Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake and recruitment for inotropic reserve in chronic left ventricular ischaemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation[J]. Circulation, 1996, 94(4):651-659.
[3] Dicarli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischemic cardiomyopathy[J]. Circulation, 1995, 92(12):3436-3444.
[4] Erie Q, Chen S, William J, et al. Myocardial viability studies using fluorine-18-FDG PET[J]. J Nucl Med, 1997, 38(4):582-586.
[5] Srinivasan G, Kitsou AN, Bacharach SL, et al.[18F]Fluorodeoxyglucose single photon emission conmputered tomography:Can it replace PET and Thallium SPECT for the assessment of myocardial viability[J]. Circulation, 1998, 97(9):843-850.
[6] Yamagishi H, Akioka K, Takagi M, et al. Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction[J]. Heart, 1999, 81(1):17-24.
[7] Duncan BH, Ahlberg AW, Levine MG, et al. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability[J]. Am J Cardiol, 2000, 85(6):680-684.
[8] Kaltoft A, Bottcher M, Sand NP, et al. 99Tcm-Sestamibi SPECT is a useful technique for viability detection:results of a comparison with NH3/FDG PET[J]. Scand Cardiovasc J, 2001, 35(4):245-251.
[9] Altehoefer C, Dahl JV, Messmer BJ, et al. Fate of the resting perfusion defect as assessed with technetium-99m methoxy-isobutyl-isonitrile single-photon emission computed tomography after successful revascularization in patients with healed myocardial infarction[J]. Am J Cardiol, 1996, 77(1):88-92.
[10] Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with 123I fatty acid and 201Tl to assess ischemic myocardium:comparison with thallium redistribution and glucose metabolism[J]. Ann Nucl Med, 1994, 8(1):47-54.
[11] Knapp FF, Franken P, Kropp J, et al. Cardiac SPECT with iodine-123-labeled fatty acids:evaluation of myocardial viability with BMIPP[J]. J Nucl Med, 1995, 36(6):1022-1030.
[12] Keiichiro Y, Koichi M, Satohi Y, et al. Low-dose dobutamine electrocardiography-gated myocardial SPECT for identifying viable myocardium:Comparison with dobutamine stress echocardiography and PET[J]. J Nucl Med, 2001, 42:838-844.
[13] Sozzi FB, Poldermans D, Bax JJ, et al. Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography[J]. Heart, 2001, 86(6):672-678.
[14] Zaglavara T, Haaverstad R, Cumberledge B, et al. Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking β blockers:accuracy and optimal dose[J]. Heart, 2002, 87(4):329-335.
[15] Charles BH. Prediction of myocardial viability by MRI[J]. Circulation, 1999, 99(6):727-729.
[16] Rogers WJ, Kramer CM, Geskin G, et al. Early contrastenhanced MRI predicts late functional recovery after reperfused myocardial infarction[J]. Circulation, 1999, 99(6):744-750.
[17] Wahba FF, Lamb HJ, Bax JJ, et al. Assessment of regional myocardial wall motion and thickening by gated 99Tcm-tetrofosmin SPECT:a comparison with magnetic resonance imaging[J]. Nucl Med Commun, 2001, 22(6):663-671.

相似文献/References:

[1]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):1.
[2]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):10.
[3]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):148.
[4]王勤奋.心肌活力测定的研究进展[J].国际放射医学核医学杂志,2005,29(4):155.
　WANG Qin-fen.The progress of research on the assessment of viable myocardium[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):155.
[5]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):197.
[6]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):201.
[7]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):205.
[8]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):209.
[9]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):213.
[10]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):216.

备注/Memo

备注/Memo:
收稿日期:2002-08-05。
作者简介:许长德(1973-),男,山东曹县人,博士研究生,主要从事核心脏病学研究。
更新日期/Last Update: 1900-01-01